Dr. Saima Aslam, MD

Dr. Aslam practices at UCSD Hillcrest Medical Center in San Diego, California.

Dr. Aslam's NPI, 1477565257, was assigned on August 12, 2006. Dr. Aslam graduated from Aga Khan Medical College in 1999. Dr. Aslam holds California license A112604.

Dr. Aslam's primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (619) 543-6222.

Dr. Aslam's primary practice is UCSD Hillcrest Medical Center in San Diego, California. Dr. Aslam is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Aslam practices. Vendor and product names are available with a free account.

Infectious disease is Dr. Aslam's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Aslam is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Aslam's licenses on file in 2 states: California and Texas.

Dmand AI lists hiv/aids, immune deficiency disease, joint or bone infection and UTI among the conditions Dr. Aslam treats.

CMS data shows 364 Medicare services from Dr. Aslam across 6 procedure codes in 2024, for 134 Medicare patients. Medicare paid $40,475 for them.

CMS counts 134 Medicare patients who saw Dr. Aslam in 2024. The largest group is 65 to 74, with 68 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 54% are also on Medicaid. Their average risk score is 5.01, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Aslam's median patient age at 59, with 42% women.

In 2024, Dr. Aslam wrote 284 Medicare Part D claims for 58 patients. 87% of them were for generic drugs. CMS names the drug for 171 of them, across 9 drugs with 11 or more claims each, at $28,252 in total drug cost. In 2023, CMS named 126 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Aslam for performance year 2024, reported as part of a group. Dr. Aslam accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Aslam as offering telehealth.

Dmand AI links 78 papers to Dr. Aslam, published from 2005 to 2025. 2021 was the busiest year, with 9. The most frequent topics are Anti-Bacterial Agents, COVID-19 and Transplant Recipients. Dr. Aslam has published most often in J Heart Lung Transplant. Dr. Aslam's most frequent co-authors are Robert Turner Schooley, MD, Eric David Adler, MD and Rabih O. Darouiche, MD.

Dmand AI links Dr. Aslam to 5 clinical trials. 3 are still active or recruiting. Conditions studied include Acquired Immunodeficiency Syndrome, Slow Virus Diseases and Kidney Failure, Chronic. Johns Hopkins University sponsors the most, 3.

CMS Open Payments shows 22 general payments to Dr. Aslam from 4 drug and device companies from 2016 to 2021. Travel and lodging make up the largest share, 53% of the total. Merck Sharp & Dohme Corporation paid the most, $22,400.

Dr. Aslam graduated from Aga Khan Medical College in 1999.

Dr. Aslam is in network with 16 carriers, including Blue Cross Blue Shield of Michigan, United Healthcare and Elevance. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.